Fiocruz COVID-19 Genomic Surveillance Network, Fiocruz, Rio de Janeiro 21040-360, Brazil.
Laboratory of Respiratory Viruses and Measles (LVRS), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21045-900, Brazil.
Viruses. 2021 Apr 21;13(5):724. doi: 10.3390/v13050724.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Brazil was dominated by two lineages designated as B.1.1.28 and B.1.1.33. The two SARS-CoV-2 variants harboring mutations at the receptor-binding domain of the Spike (S) protein, designated as lineages P.1 and P.2, evolved from lineage B.1.1.28 and are rapidly spreading in Brazil. Lineage P.1 is considered a Variant of Concern (VOC) because of the presence of multiple mutations in the S protein (including K417T, E484K, N501Y), while lineage P.2 only harbors mutation S:E484K and is considered a Variant of Interest (VOI). On the other hand, epidemiologically relevant B.1.1.33 deriving lineages have not been described so far. Here we report the identification of a new SARS-CoV-2 VOI within lineage B.1.1.33 that also harbors mutation S:E484K and was detected in Brazil between November 2020 and February 2021. This VOI displayed four non-synonymous lineage-defining mutations (NSP3:A1711V, NSP6:F36L, S:E484K, and NS7b:E33A) and was designated as lineage N.9. The VOI N.9 probably emerged in August 2020 and has spread across different Brazilian states from the Southeast, South, North, and Northeast regions.
巴西的严重急性呼吸系统综合征冠状病毒 2 (SARS-CoV-2) 疫情主要由两个谱系主导,分别指定为 B.1.1.28 和 B.1.1.33。两种在 Spike (S) 蛋白受体结合域带有突变的 SARS-CoV-2 变体,指定为谱系 P.1 和 P.2,源自谱系 B.1.1.28,并在巴西迅速传播。谱系 P.1 因其 S 蛋白中存在多个突变(包括 K417T、E484K、N501Y)而被认为是关切变体 (VOC),而谱系 P.2 仅携带突变 S:E484K,被认为是感兴趣变体 (VOI)。另一方面,目前尚未描述具有流行病学意义的 B.1.1.33 衍生谱系。在这里,我们报告了在谱系 B.1.1.33 内鉴定出一种新的 SARS-CoV-2 VOI,该变体也携带突变 S:E484K,并于 2020 年 11 月至 2021 年 2 月在巴西检测到。该 VOI 显示出四个非同义谱系定义突变(NSP3:A1711V、NSP6:F36L、S:E484K 和 NS7b:E33A),并被指定为谱系 N.9。VOI N.9 可能于 2020 年 8 月出现,并已从东南部、南部、北部和东北部的不同巴西州传播。